Skip to content

MEDIFARM+: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDIFARM+

BE 0629.857.424
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€136,111
2024 · €190,109-€53,998
Equity
€255,409
2024 · €235,299+€20,111
Cash
€232,316
2024 · €140,154+€92,162
Balance sheet total
€2.8m
2024 · €2.4m+€333,370

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€203,462

    up €203,462 (+34.3%), from €593,472 to €796,934

    of which Plant, machinery and equipment: +€219,911

  • Cash +€92,162

    up €92,162 (+65.8%), from €140,154 to €232,316

    mainly Trade debts (+€293,965) and Net result for the year (+€136,111)

  • Intangible fixed assets -€88,957

    down €88,957 (-11.1%), from €800,610 to €711,653

  • Receivables within one year +€85,190

    up €85,190 (+26.1%), from €326,779 to €411,970

    of which Other amounts receivable: +€104,079

  • Stocks and contracts +€42,539

    up €42,539 (+7.7%), from €549,815 to €592,354

Equity and liabilities
  • Trade debts +€293,965

    up €293,965 (+106%), from €276,792 to €570,757

  • Debts after one year -€101,481

    down €101,481 (-6.8%), from €1.5m to €1.4m

  • Other debts +€80,744

    up €80,744 (+31.1%), from €260,000 to €340,744

Income statement
  • Gross operating margin -€163,528

    down €163,528 (-21.1%), from €775,204 to €611,676

  • Staff costs -€99,904

    down €99,904 (-23.4%), from €426,312 to €326,409

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €190,109
Gross operating margin -€163,528
Staff costs +€99,904
Depreciation -€263
Other operating charges -€545
Financial income -€728
Financial charges +€3,519
Taxes +€7,643
Result 2025 €136,111
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€526,020
Investment -€231,964
Financing -€201,894
Cash 2024 €140,154
Net result for the year +€136,111
Depreciation +€117,458
Stocks and contracts -€42,539
Receivables within one year -€85,190
Deferred charges and accrued income +€1,026
Trade debts +€293,965
Tax, wage and social debts +€22,082
Advances received +€2,363
Other debts +€80,744
Investment in fixed assets (net) -€231,964
Debts after one year -€101,481
Current portion of long-term debt +€15,588
Contributions, distributions and other -€116,000
Cash 2025 €232,316
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,418,944 €2,752,314 +€333,370 +13.8%
Fixed assets 21/28 €1,395,165 €1,509,670 +€114,505 +8.2%
Intangible fixed assets 21 €800,610 €711,653 -€88,957 -11.1%
Tangible fixed assets 22/27 €593,472 €796,934 +€203,462 +34.3%
Land and buildings 22 €547,444 €540,630 -€6,814 -1.2%
Plant, machinery and equipment 23 €26,515 €246,427 +€219,911 +829%
Furniture and vehicles 24 €19,513 €9,878 -€9,635 -49.4%
Financial fixed assets 28 €1,082 €1,082 = 0.0%
Current assets 29/58 €1,023,779 €1,242,644 +€218,865 +21.4%
Stocks and contracts in progress 3 €549,815 €592,354 +€42,539 +7.7%
Stocks 30/36 €549,815 €592,354 +€42,539 +7.7%
Amounts receivable within one year 40/41 €326,779 €411,970 +€85,190 +26.1%
Trade receivables 40 €262,447 €243,558 -€18,889 -7.2%
Other amounts receivable 41 €64,332 €168,411 +€104,079 +162%
Cash at bank and in hand 54/58 €140,154 €232,316 +€92,162 +65.8%
Deferred charges and accrued income 490/1 €7,031 €6,005 -€1,026 -14.6%
Total equity and liabilities 10/49 €2,418,944 €2,752,314 +€333,370 +13.8%
Equity 10/15 €235,299 €255,409 +€20,111 +8.5%
Contributions 10/11 €62,358 €62,358 = 0.0%
Reserves 13 €172,941 €193,051 +€20,111 +11.6%
Non-distributable reserves 130/1 €6,236 €6,236 = 0.0%
Reserves not available under the articles 1311 €6,236 €6,236 = 0.0%
Tax-exempt reserves 132 €7,920 €7,920 = 0.0%
Distributable reserves 133 €158,785 €178,896 +€20,111 +12.7%
Amounts payable 17/49 €2,183,645 €2,496,905 +€313,260 +14.3%
Amounts payable after more than one year 17 €1,486,558 €1,385,077 -€101,481 -6.8%
Financial debts 170/4 €1,486,558 €1,385,077 -€101,481 -6.8%
Amounts payable within one year 42/48 €697,087 €1,111,828 +€414,741 +59.5%
Current portion of amounts payable after more than one year 42 €99,728 €115,316 +€15,588 +15.6%
Trade debts 44 €276,792 €570,757 +€293,965 +106%
Suppliers 440/4 €276,792 €570,757 +€293,965 +106%
Advances received on contracts in progress 46 - €2,363 +€2,363
Taxes, remuneration and social security 45 €60,567 €82,649 +€22,082 +36.5%
Taxes 450/3 €15,435 €41,764 +€26,329 +171%
Remuneration and social security 454/9 €45,132 €40,884 -€4,248 -9.4%
Other amounts payable 47/48 €260,000 €340,744 +€80,744 +31.1%
Remuneration, social security and pensions 62 €426,312 €326,409 -€99,904 -23.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €117,195 €117,458 +€263 +0.2%
Other operating charges 640/8 €2,650 €3,194 +€545 +20.6%
Gross operating margin 9900 €775,204 €611,676 -€163,528 -21.1%
Operating profit (loss) 9901 €229,047 €164,615 -€64,432 -28.1%
Financial income 75/76B €728 €0 -€728 -100.0%
Recurring financial income 75 €728 €0 -€728 -100.0%
Financial charges 65/66B €31,998 €28,479 -€3,519 -11.0%
Recurring financial charges 65 €31,998 €28,479 -€3,519 -11.0%
Profit (loss) for the period before taxes 9903 €197,777 €136,136 -€61,641 -31.2%
Income taxes 67/77 €7,668 €25 -€7,643 -99.7%
Profit (loss) for the period 9904 €190,109 €136,111 -€53,998 -28.4%
Profit (loss) for the period to be appropriated 9905 €190,109 €136,111 -€53,998 -28.4%

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.